Antengene raises $120m amid China anti-cancer push
It is the fourth nine-figure private fundraising by a Chinese pharmaceutical company involved in cancer research in nine months.
January 02, 2019
- News
-
Investment Lifecycle
Deals & Trends
Rainmakers
Regions
- Research
-
- Awards
-
- Events
- Photo Gallery
